Brimonidine vs ALTP in Progressing Human Glaucoma

Summary

This study is evaluating possible non-intraocular pressure (IOP) related effects of the alpha-1 agonist brimonidine in human subjects affected by a progressive glaucomatous optic neuropathy. Brimonidine was proven as neuroprotective in several pre-clinical animal studies.

Timeline

Start

1999-08

Primary completion

—

Completion

2002-10

Drugs

Indications